Evaluation of bone repair of critical size defects treated with simvastatin-loaded poly(lactic- co -glycolic acid) microspheres in rat calvaria

Abstract

Purpose

Statins are hypolipemiant drugs with osteoinductive effect. We evaluated the potential of simvastatin loaded into poly(lactic-co-glycolic acid) (PLGA) microspheres to heal critical size defects in rat calvaria.

Methods

PLGA scaffolds (50:50 ratio) were synthesized as pure membranes or as microspheres loaded with 2.5% simvastatin. Critical size defects (5-mm diameter) were created in the parietal bone of 3-month-old male Wistar rats; they were either left filled with blood clot (C group), covered with a PLGA membrane (M group) or with PLGA microspheres loaded with simvastatin (MSI group) or not (MM group), and then covered with the PLGA membrane. The defects were evaluated after 30 or 60 days by light and electron microscopy, immunohistochemistry for osteopontin (OPN), bone sialoprotein (BSP) and osteoadherin (OSAD), and immunocytochemistry for OPN.

Results

Scanning electron microscopy showed that the calvarial defects treated with MSI were almost completely healed after 60 days, while groups M and C presented less bone formation, whereas the bone matrix formed into the defects of MSI group was more organized and mature. The immunolabeling for OPN and BSP on the matrix in groups C and M showed typical areas of primary bone unlike the MSI that presented weak labeling at the formed area. In the MSI group, there was an intense immunostaining for OSAD in osteoid, as well as in osteocyte cytoplasm. The immunocytochemistry showed intense labeling for OPN with homogeneous distribution in the interfibrillar spaces in all groups after 30 days and after 60 days; however, while C and M groups exhibited similar aspect, the MSI specimens showed weak labeling. The ultrastructural evaluation showed the interaction between the biomaterial and the surrounding tissue where some cells established intimate contact with microspheres.

Conclusions

The repair of critical size bone defects was accelerated and enhanced by the implantation of simvastatin-loaded PLGA microspheres.

Keywords

Bone regeneration osteoconduction osteoinduction PLGA simvastatin

Get full access to this article

View all access options for this article.

References

Scaglione

Lazzarini

Ilengo

. A composite material model for improved bone formation. J Tissue Eng Regen Med 2010; 4: 505–513.

Garrett

Gutierrez

Mundy

. Statins and bone formation. Curr Pharm Des 2001; 7: 715–736.

Mundy

Garrett

Harris

. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286: 1946–1949.

Davignon

Laaksonen

. Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol 1999; 10: 543–559.

Jadhav

Jain

. Statins and osteoporosis: New role for old drugs. J Pharm Pharmacol 2006; 58: 3–18.

Oxlund

Andreassen

. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 2004; 34: 609–618.

Skoglund

Aspenberg

. Locally applied simvastatin improves fracture healing in mice. BMC Musculoskelet Disord 2007; 27: 98–98.

Maciel-Oliveira

Bradaschia-Correa

Arana-Chavez

. Early alveolar bone regeneration in rats after topical administration of simvastatin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112: 170–179.

Tai

Wang

. Local delivery of controlled-release simvastatin PLGA/HAp microspheres enhances bone repair. Int J Nanomed 2013; 8: 3895–3904.

10.

Naito

Terukina

Galli

. The effect of simvastatin-loaded polymeric microspheres in a critical size bone defect in the rabbit calvaria. Int J Pharm 2014; 461: 157–162.

11.

Stein

Lee

Schmid

. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol 2005; 76: 1861–1870.

12.

Mano

Sousa

Boesel

. Bioinert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: state of the art and recent developments. Compos Sci Tech 2004; 64: 789–817.

13.

Barbanti

Santos

Jr Zavaglia

. Porous and dense poly(l-lactic acid) and poly(d,l-lactic acid-co-glycolic acid) scaffolds: in vitro degradation in culture medium and osteoblasts culture. J Mater Sci Mater Med 2004; 15: 1315–1321.

14.

Pietro

Silva

do Carmo Alberto-Rincon

. The microscopical characterization of membranes poly(l-glycolic-co-lactic acid) with and without added plasticizer: an in vivo study. J Mater Sci Mater Med 2008; 19: 1069–1071.

15.

Chang

Chung

Lei

. Biocompatibility of PDGF-simvastatin double-walled PLGA (PDLLA) microspheres for dentoalveolar regeneration: a preliminary study. J Biomed Mater Res A 2012; 100: 2970–2978.

16.

Opperman

. Cranial sutures as intramembranous bone growth sites. Dev Dyn 2000; 219: 472–485.

17.

Garrett

Gutierrez

Rossini

. Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J Orthop Res 2007; 25: 1351–1357.

18.

Cameron

Milner

Lee

. Employing the biology of successful fracture repair to heal critical size bone defects. Curr Top Microbiol Immunol 2013; 367: 113–132.

19.

Massa

Arana-Chavez

. Ultrastructural preservation of rat embryonic dental tissues after rapid fixation and dehydration under microwave irradiation. Eur J Oral Sci 2000; 108: 74–77.

20.

Couble

Bleicher

Farges

. Immunodetection of osteoadherin in murine tooth extracellular matrices. Histochem Cell Biol 2004; 121: 47–53.

21.

Arana-Chavez

Nanci

. High-resolution immunocytochemistry of noncollagenous matrix proteins in rat mandibles processed with microwave irradiation. J Histochem Cytochem 2001; 49: 1099–1109.

22.

Nath

Linh

Sadiasa

. Encapsulation of simvastatin in PLGA microspheres loaded into hydrogel loaded BCP porous spongy scaffold as a controlled drug delivery system for bone tissue regeneration. J Biomater Appl 2014; 28: 1151–6323.

23.

Imbronito

Scarano

Orsini

. Ultrastructure of bone healing in defects grafted with a copolymer of polylactic/polyglycolic acids. J Biomed Mater Res A 2005; 74: 215–221.

24.

Berkland

King

Cox

. Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release 2002; 82: 137–147.

25.

Sinha

Bansal

Kaushik

. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004; 278: 1–23.

26.

Ramstad

Franzén

Heinegård

. Ultrastructural distribution of osteoadherin in rat bone shows a pattern similar to that of bone sialoprotein. Calcif Tissue Int 2003; 72: 57–64.

27.

Jeon

Piepgrass

Lin

. Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats. J Periodontol 2008; 79: 1457–1464.

28.

Brown JL, Kumbar SG and Laurencin CT. Bone tissue engineering. In: Ratner BD, Schoen J, Hoffman AS and Lemons JE (eds) Biomaterials Science: An Introduction to Materials in Medicine, 3th ed., Chapter II.6.7, Oxford: Elsevier, 2013, pp. 1194–1197.

29.

Adeeb

Mortazavi

Tubbs

. The cranial dura mater: a review of its history, embryology, and anatomy. Childs Nerv Syst 2012; 28: 827–837.

30.

Rey

Combes

Drouet

. Bone mineral: update on chemical composition and structure. Osteoporos Int 2009; 20: 1013–1021.

31.

Arana-Chavez

Soares

Katchburian

. Junctions between early developing osteoblasts of rat calvaria as revealed by freeze-fracture and ultrathin section electron microscopy. Arch Histol Cytol 1995; 58: 285–292.

32.

. In vitro degradation, biocompatibility, and in vivo osteogenesis of poly(lactic-co-glycolic acid)/calcium phosphate cement scaffold with unidirectional lamellar pore structure. J Biomed Mater Res A 2012; 100: 3239–50.

33.

Brinkkoetter

Ising

Benzing

. The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013; 9: 328–336.

34.

Song

Guo

. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003; 308: 458–462.